Spyre Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spyre Therapeutics, Inc. has filed 781 SEC EDGAR filings since 24 Mar 2015

SEC filing history

Showing 126-150 of 781 matching filings.

Per page
25
Current page
6
4

FORM 4

Filing date
08 Nov 2024
Reporting date
06 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89456

SC 13G filing

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-283065

S-8

Filing date
07 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Oct 2024
Reporting date
25 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37722

144 filing

Filing date
25 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89456

SCHEDULE 13G

Filing date
23 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89456

SC 13G filing

Filing date
22 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-282252

EFFECT filing

Filing date
02 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Oct 2024
Reporting date
01 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
01 Oct 2024
Reporting date
01 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
30 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-282252

UPLOAD filing

Filing date
26 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-282252

S-3

Filing date
20 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-281975

EFFECT filing

Filing date
18 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-281975

UPLOAD filing

Filing date
12 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-281975

S-3

Filing date
06 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Sep 2024
Reporting date
03 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-278810

424B3

Filing date
08 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .